CDT Research Study for Individuals with Type 1 Diabetes and using the Tandem Control-IQ pump

UVA Tracking #
Principal Investigator
Sue A Brown
Olivia McLean
Contact Email
Contact Phone
Official Trial Title
Adaptive Automated Insulin Delivery (AID) Based on Predetermined Classification of Daily CGM Profiles: A Pilot Study
Study Description

The UVA Center for Diabetes Technology seeks adults 18 years or older who have Type 1 Diabetes and is currently using a Tandem Control-IQ (CIQ) insulin pump to participate in a research study.

The purpose of this study is to assess the safety of a weekly adjustment to your insulin parameters using a table that developed by the study team. The goal of these insulin parameter adjustments is aimed at reducing hypoglycemic and hyperglycemic events that you may experience. During the 6 week study, you will use your personal CIQ with your usual insulin parameters for 3 weeks, and you will use your personal CIQ with insulin parameters generated by the study team for 3 weeks.

You may be eligible for this study if:
• Age =18 years of age
• Clinical diagnosis, based on investigator assessment, of type 1 diabetes for at least 1 year
• Currently using insulin for at least six months
• Currently using the CIQ insulin pump

Study-related Hemoglobin A1c, pregnancy test, and physical exam (if one hasn’t been done in the last 12 months) provided free of charge.


Compensation for study completion is $400. You will be provided continuous glucose monitoring supplies to use during the study.